Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ALT Stock Annual Income Statement. Download in Excel

Altimmune Inc. logo

Altimmune Inc.

Sector: Healthcare   

Industry: Biotechnology

6.74
 
USD
  
0.00
  
(0.00%)
Previous close: 6.74  Open: 6.82  Bid: 6.71  Ask: 6.74
52 week range    
2.32   
   14.84
Mkt Cap: 523 M  Avg Vol (90 Days): 2,165,314
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Monday 4th November 2024

Stock Rankings

52
MarketXLS Rank
60
Value
46
Technical
50
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

ALT Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends368548.05 M3 M452925.0
Amortization of intangibles13 M12 M12 M
Basic EPS from continuing operations-1.91-2.35-1.81-1.66
Basic EPS total-1.2-0.689.1-1.91-2.35-1.81-1.66
Basic weighted shares outstanding2 M2 M2 M426836.03 M13 M26 M41 M47 M53 M
Cost of sales-100000.0-100000.0
Depreciation149958.0141604.0-63109.0-83834.0-218717.0-239821.0300000.0400000.0500000.0500000.0
Depreciation unreconciled149958.0141604.0143437.0
DepreciationAndAmortization149958.0141604.0-63109.0-83834.0-218717.0-239821.0300000.0400000.0500000.0500000.0
Diluted EPS total-5.1-1.588.5-120.3-15.16-1.6-1.91-2.35-1.81-1.66
Diluted normalized net income/share-2.35-1.81-1.66
Diluted weighted shares outstanding2 M2 M2 M385913.03 M13 M26 M41 M47 M53 M
GainOnSaleOfSecurity508817.0299477.0-957070.090384.0-3 M30000.0
GeneralAndAdministrativeExpense11 M6 M7 M8 M10 M9 M13 M15 M17 M18 M
Gross operating profit10 M11 M3 M11 M10 M6 M8 M4 M-68000.0426000.0
ImpairmentOfCapitalAssets36 M25 M1000000.0579000.0
Income before tax-10 M-3 M-11 M-52 M-45 M-21 M-54 M-97 M-85 M-88 M
Income restructuring and M&A3 M-249643.0
Income taxes61746.061746.011 M-6 M-6 M-58500.0-5 M-200000.0
Interest income-229192.01047.047579.0226597.0873409.0322514.0203000.03 M7 M
InterestExpenseNonOperating210399.054581.038499.0162139.0297090.02244.09421.05000.08000.035000.0
MiscOtherSpecialCharges-762.08137.042303.05670.0277886.015139.024147.0-374000.0-32000.0166000.0
Net income from total operations-10 M-3 M-11 M-46 M-39 M-21 M-49 M-97 M-85 M-88 M
NetIncomeCommonStockholders-10 M-3 M-11 M-51 M-42 M-21 M-49 M-97 M-85 M-88 M
NetIncomeContinuousOperations-10 M-3 M-11 M-46 M-39 M-21 M-49 M-97 M-85 M-88 M
NetNonOperatingInterestIncomeExpense-210399.0-229192.0-37452.0-114560.0-70493.0871165.0313093.0198000.03 M7 M
NetOperatingInterestIncomeExpense-54581.0168150.0
NonRecurringOperationExpense-217 M
Normalized income-57 M
Operating income-10 M-856641.0-11 M-16 M-18 M-20 M-55 M-97 M-88 M-96 M
Operating income before depreciation (EBITDA)-10 M-3 M-11 M-52 M-45 M-20 M-54 M-97 M-84 M-88 M
OperatingExpense-20 M-14 M-14 M-63 M-53 M-27 M63 M101 M88 M84 M
Other income net-508055.0-307614.0-42303.0-96054.02 M-15139.0-24147.012 M32000.0-12 M
OtherGandA11 M6 M7 M8 M10 M9 M13 M15 M17 M18 M
OtherImpairmentOfCapitalAssets-36981.0-24 M-1000000.011 M12 M
OtherOperatingExpenses-710783.0500000.0500000.0500000.0
OtherunderPreferredStockDividend368548.05 M3 M452925.0
PreferredStockDividends368548.05 M3 M452925.0
RentAndLandingFees11 M6 M7 M8 M10 M9 M407200.0
Research & development expense9 M5 M7 M18 M18 M18 M50 M75 M71 M66 M
ResearchExpense9 M5 M7 M18 M18 M18 M50 M75 M71 M66 M
RestructringAndMnAIncome3 M-249643.0
Revenue per share13 M12 M12 M
SalariesAndWages-2 M-613017.0-965365.0-1 M-773248.0-1 M3 M6 M8 M
Selling Gen & administrative expense11 M6 M7 M8 M10 M9 M13 M15 M17 M18 M
Special income/charges-3 M217 M-36 M-25 M-1000000.0-579000.0
Total Income available for interest expense (EBIT)-10 M-3 M-11 M-52 M-45 M-21 M-54 M-97 M-85 M-88 M
Total common shares outstanding212109.0217504.0229383.0742369.013 M15 M37 M43 M49 M71 M
Total net income-10 M-3 M-11 M-46 M-39 M-21 M-49 M-97 M-85 M-88 M
Total ordinary shares71 M71 M71 M71 M71 M71 M71 M71 M71 M71 M
Total revenues10 M11 M3 M11 M10 M6 M8 M4 M-68000.0426000.0
TotalExpenses-20 M-14 M-14 M-63 M-53 M-27 M63 M101 M88 M84 M
TotalRevenue10 M11 M3 M11 M10 M6 M8 M4 M-68000.0426000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University